Herein, we report that the hypomethylation at non-CpG and CpG sites in the promoter around its transcription start site (TSS) is an important reason to increase HIF-1α expression in those breast cancer cells or tissue samples with highly malignant behavior. The gene discussed is HIF1A; the disease is breast cancer.